Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells

BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anticancer drugs but their effect on tumor treatment has been disappointing mainly due to the acquisition of HDAC inhibitor resistance. However, the mechanisms underlying such resistance remain unclear. METHODS: In this study, we perfor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Res
Main Authors: Hwang, Won Chan, Kang, Dong Woo, Kang, Youra, Jang, Younghoon, Kim, Jung-Ae, Min, Do Sik
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528251/
https://ncbi.nlm.nih.gov/pubmed/32998768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40659-020-00294-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki